{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Euplotes : Questions médicales les plus fréquentes",
"headline": "Euplotes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Euplotes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-12",
"dateModified": "2025-02-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Euplotes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sporadotrichina",
"url": "https://questionsmedicales.fr/mesh/D016811",
"about": {
"@type": "MedicalCondition",
"name": "Sporadotrichina",
"code": {
"@type": "MedicalCode",
"code": "D016811",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.043.185.700.400.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Euplotes",
"alternateName": "Euplotes",
"code": {
"@type": "MedicalCode",
"code": "D016812",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Adriana Vallesi",
"url": "https://questionsmedicales.fr/author/Adriana%20Vallesi",
"affiliation": {
"@type": "Organization",
"name": "School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, MC, Italy. adriana.vallesi@unicam.it."
}
},
{
"@type": "Person",
"name": "Pierangelo Luporini",
"url": "https://questionsmedicales.fr/author/Pierangelo%20Luporini",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Eukaryotic Microbiology and Animal Biology, School of Biosciences and Veterinary Medicine, University of Camerino, Camerino 62032, Italy."
}
},
{
"@type": "Person",
"name": "Yaohan Jiang",
"url": "https://questionsmedicales.fr/author/Yaohan%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, MC, Italy; Institute of Evolution & Marine Biodiversity, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Claudia Vannini",
"url": "https://questionsmedicales.fr/author/Claudia%20Vannini",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Pisa, Pisa, 56126, Italy."
}
},
{
"@type": "Person",
"name": "Graziano Di Giuseppe",
"url": "https://questionsmedicales.fr/author/Graziano%20Di%20Giuseppe",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Pisa, Pisa, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cellular and Molecular Diversity in Scleroderma.",
"datePublished": "2022-08-06",
"url": "https://questionsmedicales.fr/article/35940960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.smim.2022.101648"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.",
"datePublished": "2024-08-23",
"url": "https://questionsmedicales.fr/article/39273131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179182"
}
},
{
"@type": "ScholarlyArticle",
"name": "Barriers and Facilitators to Physical Activity for People With Scleroderma: A Scleroderma Patient-Centered Intervention Network Cohort Study.",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/33527717",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acr.24567"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pulmonary Hypertension in Scleroderma- Evaluation and Management.",
"datePublished": "2022-09-24",
"url": "https://questionsmedicales.fr/article/36163292",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.disamonth.2022.101468"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36244404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.chest.2022.09.044"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Alveolata",
"item": "https://questionsmedicales.fr/mesh/D056893"
},
{
"@type": "ListItem",
"position": 4,
"name": "Ciliophora",
"item": "https://questionsmedicales.fr/mesh/D016798"
},
{
"@type": "ListItem",
"position": 5,
"name": "Polymenophorea",
"item": "https://questionsmedicales.fr/mesh/D016809"
},
{
"@type": "ListItem",
"position": 6,
"name": "Hypotrichida",
"item": "https://questionsmedicales.fr/mesh/D016810"
},
{
"@type": "ListItem",
"position": 7,
"name": "Sporadotrichina",
"item": "https://questionsmedicales.fr/mesh/D016811"
},
{
"@type": "ListItem",
"position": 8,
"name": "Euplotes",
"item": "https://questionsmedicales.fr/mesh/D016812"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Euplotes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Euplotes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Euplotes",
"description": "Comment identifier les Euplotes dans un échantillon d'eau ?\nQuels tests sont utilisés pour étudier les Euplotes ?\nLes Euplotes peuvent-ils être confondus avec d'autres organismes ?\nQuels outils sont nécessaires pour le diagnostic des Euplotes ?\nQuelle est la taille typique des Euplotes ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Euplotes",
"description": "Quels symptômes sont associés aux infections par Euplotes ?\nLes Euplotes provoquent-ils des maladies chez l'homme ?\nQuels effets les Euplotes ont-ils sur les écosystèmes aquatiques ?\nLes Euplotes peuvent-ils affecter d'autres organismes aquatiques ?\nComment les Euplotes se déplacent-ils ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Euplotes",
"description": "Comment prévenir la prolifération des Euplotes dans les étangs ?\nQuelles mesures peuvent réduire les Euplotes dans les aquariums ?\nLes Euplotes peuvent-ils être introduits accidentellement ?\nComment éviter la contamination des eaux par les Euplotes ?\nLes Euplotes sont-ils affectés par les traitements de l'eau ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Euplotes",
"description": "Quels traitements sont disponibles pour les infections par Euplotes ?\nComment contrôler les populations d'Euplotes dans les aquariums ?\nLes Euplotes nécessitent-ils des soins particuliers en laboratoire ?\nQuels produits chimiques affectent les Euplotes ?\nLes Euplotes sont-ils sensibles aux changements de température ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Euplotes",
"description": "Quelles complications peuvent survenir avec les Euplotes ?\nLes Euplotes peuvent-ils causer des déséquilibres écologiques ?\nComment les Euplotes affectent-ils la biodiversité ?\nLes Euplotes sont-ils un indicateur de pollution ?\nLes Euplotes peuvent-ils être nuisibles aux poissons ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Euplotes",
"description": "Quels facteurs augmentent la présence des Euplotes ?\nLes changements climatiques affectent-ils les Euplotes ?\nLes Euplotes sont-ils sensibles à la pollution ?\nQuels types d'eaux favorisent les Euplotes ?\nLes Euplotes sont-ils affectés par les activités humaines ?",
"url": "https://questionsmedicales.fr/mesh/D016812?mesh_terms=Scleroderma,+Systemic&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les Euplotes dans un échantillon d'eau ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'observation microscopique permet de détecter les Euplotes grâce à leur forme caractéristique."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier les Euplotes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de culture et des tests de coloration sont souvent utilisés pour les identifier."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être confondus avec d'autres organismes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec d'autres protozoaires ciliés sans une observation minutieuse."
}
},
{
"@type": "Question",
"name": "Quels outils sont nécessaires pour le diagnostic des Euplotes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un microscope à lumière et des préparations d'échantillons sont essentiels pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quelle est la taille typique des Euplotes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Euplotes mesurent généralement entre 50 et 200 micromètres de long."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés aux infections par Euplotes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections par Euplotes sont rares, mais peuvent causer des troubles digestifs chez les hôtes."
}
},
{
"@type": "Question",
"name": "Les Euplotes provoquent-ils des maladies chez l'homme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les Euplotes ne sont pas pathogènes pour l'homme et ne causent pas de maladies."
}
},
{
"@type": "Question",
"name": "Quels effets les Euplotes ont-ils sur les écosystèmes aquatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils jouent un rôle dans la chaîne alimentaire et la décomposition des matières organiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils affecter d'autres organismes aquatiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la population d'autres protozoaires et microorganismes dans leur habitat."
}
},
{
"@type": "Question",
"name": "Comment les Euplotes se déplacent-ils ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se déplacent grâce à des cils qui battent de manière coordonnée, leur permettant de nager."
}
},
{
"@type": "Question",
"name": "Comment prévenir la prolifération des Euplotes dans les étangs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'eutrophisation et maintenir un bon équilibre écologique aide à prévenir leur prolifération."
}
},
{
"@type": "Question",
"name": "Quelles mesures peuvent réduire les Euplotes dans les aquariums ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un entretien régulier et un contrôle de la qualité de l'eau sont essentiels pour limiter leur croissance."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être introduits accidentellement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être introduits par des plantes aquatiques ou des équipements contaminés."
}
},
{
"@type": "Question",
"name": "Comment éviter la contamination des eaux par les Euplotes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter de relâcher des eaux usées non traitées dans les milieux aquatiques prévient leur introduction."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils affectés par les traitements de l'eau ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements de l'eau peuvent réduire leur population, mais doivent être utilisés avec précaution."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections par Euplotes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun traitement spécifique n'est nécessaire, car les Euplotes ne sont pas pathogènes pour l'homme."
}
},
{
"@type": "Question",
"name": "Comment contrôler les populations d'Euplotes dans les aquariums ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne qualité de l'eau et éviter la surpopulation aide à contrôler leur nombre."
}
},
{
"@type": "Question",
"name": "Les Euplotes nécessitent-ils des soins particuliers en laboratoire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils doivent être cultivés dans des conditions spécifiques pour assurer leur survie en laboratoire."
}
},
{
"@type": "Question",
"name": "Quels produits chimiques affectent les Euplotes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des désinfectants et des antibiotiques peuvent affecter leur survie dans des environnements aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils sensibles aux changements de température ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les variations de température peuvent influencer leur croissance et leur reproduction."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Euplotes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les Euplotes ne causent généralement pas de complications, car ils ne sont pas pathogènes pour l'homme."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils causer des déséquilibres écologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surpopulation d'Euplotes peut perturber l'équilibre des écosystèmes aquatiques."
}
},
{
"@type": "Question",
"name": "Comment les Euplotes affectent-ils la biodiversité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent influencer la biodiversité en interagissant avec d'autres microorganismes aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils un indicateur de pollution ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur présence peut indiquer des niveaux de pollution dans les environnements aquatiques."
}
},
{
"@type": "Question",
"name": "Les Euplotes peuvent-ils être nuisibles aux poissons ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, ils ne sont pas nuisibles aux poissons, mais une surpopulation peut affecter leur habitat."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent la présence des Euplotes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'eutrophisation et la pollution des eaux favorisent la prolifération des Euplotes."
}
},
{
"@type": "Question",
"name": "Les changements climatiques affectent-ils les Euplotes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les changements climatiques peuvent influencer leur habitat et leur reproduction."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils sensibles à la pollution ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution peut affecter leur survie et leur reproduction dans les milieux aquatiques."
}
},
{
"@type": "Question",
"name": "Quels types d'eaux favorisent les Euplotes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les eaux riches en nutriments et stagnantes sont idéales pour la prolifération des Euplotes."
}
},
{
"@type": "Question",
"name": "Les Euplotes sont-ils affectés par les activités humaines ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les activités humaines comme l'agriculture et l'urbanisation peuvent augmenter leur présence."
}
}
]
}
]
}
With the increasing armamentarium of high-throughput tools available at manageable cost, it is attractive and informative to determine the molecular underpinnings of patient heterogeneity in systemic ...
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...
To support physical activity among people with systemic sclerosis (SSc [scleroderma]), we sought to determine the prevalence and importance of barriers and the likelihood of using possible facilitator...
We invited 1,707 participants from an international SSc cohort to rate the importance of 20 barriers (14 medical, 4 social or personal, 1 lifestyle, and 1 environmental) and the likelihood of using 91...
Among 721 respondents, 13 barriers were experienced by ≥25% of participants, including 2 barriers (fatigue and Raynaud's phenomenon) rated "important" or "very important" by ≥50% of participants, 7 ba...
Medical-related physical activity barriers were common and considered important. Facilitators considered as most likely to be used involved adapting exercise, taking care of one's body, keeping warm, ...
Pulmonary Arterial Hypertension (PAH) is a clinical syndrome consisting of physiologic/hemodynamic criteria that are a consequence of several etiologies. Systemic Sclerosis (SSc), one of the most comm...
Enrichment strategies from clinical trials for progressive systemic sclerosis-associated interstitial lung disease (SSc-ILD) have not been tested in a real-life cohort....
Do enrichment strategies for progressive ILD impact efficacy, representativeness, and feasibility in patients with SSc-ILD from the European Scleroderma Trials and Research (EUSTAR) database?...
We applied the inclusion criteria of major recent SSc-ILD trials (Study of the Efficacy and Safety of Tocilizumab in Participants With Systemic Sclerosis [focuSSced], Scleroderma Lung Study II [SLS II...
In total, 2,258 patients with SSc-ILD were included: 31.2% of the patients met SENSCIS criteria; 5.8% of the patients met SLS II criteria; 1.6% of the patients met focuSSced criteria, and 67.7% (1,529...
The application of enrichment criteria from previous clinical trials showed enrichment for progression with variable success, which led to selected patient populations reducing feasibility of recruitm...
Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with...
Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi...
Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0...
Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....
One of the key clinical challenges of systemic sclerosis (SSc) is diversity in clinical presentation, organ involvement and disease progression. Antinuclear autoantibodies (ANA) are central to the dia...
There has been further development in delineating clinical patterns in ANA, genetic susceptibility and antigen triggers predisposing to ANA subtypes. Sub-group analysis of recent clinical trials shows...
ANA subtyping is likely to be firmly embedded into future classification systems. Beyond informing current management and monitoring of scleroderma patients, ANA subsets have implication on future res...
The mechanisms of systemic autoimmune diseases (ADs) are still not clearly understood. Understanding the etiology of systemic ADs and identifying new therapeutic targets require a systems science appr...
People with systemic sclerosis (SSc) are vulnerable in COVID-19 and face challenges related to shifting COVID-19 risk and protective restrictions. We evaluated mental health symptom trajectories in pe...
The longitudinal Scleroderma Patient-centred Intervention Network (SPIN) COVID-19 cohort was launched in April 2020 and included participants from the ongoing SPIN Cohort and external enrolees. Analys...
Anxiety symptoms increased in early 2020 but returned to pre-COVID-19 levels by mid-2020 and remained stable through March 2022. Depression symptoms did not initially change but were slightly lower by...
People with SSc continue to face COVID-19 challenges related to ongoing risk, the opening of societies, and removal of protective restrictions. People with SSc, in aggregate, appear to be weathering t...
Systemic sclerosis (SSc) is a rare auto-immune disease, affecting principally women between 40 and 60 years old. It is caracterised by a cutaneous and visceral fibrosis, an alteration of the microvasc...
We have analysed the data of a retrospective and bicentrique cohort, from the internal medicine unit of Hôpital Nord in Marseille and from the internal medicine unit of the Hôpital Sainte-Anne in Toul...
The cohort included 151 patients including 134 limited cutaneous SSc. Fifty-two (34.4%) patients presented at least one associated auto-immune or inflammatory disease. The association of two connectiv...
SSc is often associated with other autoimmune diseases. This interrelation between associated pathologies and SSc, modifying sometimes the evolution of SSc, enhances the need of a personalized follow-...